Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease	Chronic Disease, Disease Attributes, Disease Progression, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder	Active, not recruiting	Not stated	2025-07-24		NCT06962891

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Angel Argiles	1
Institut National de la Santé Et de la Recherche Médicale, France	219
Klinikum Bayreuth GmbH	1
Medical University Innsbruck	69
RD Néphrologie SAS	1
RWTH Aachen University	26
University of Skövde	3
University Paul Sabatier of Toulouse	5

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Klinikum Bayreuth GmbH	Bayreuth	Germany	2
Medizinische Universität Innsbruck	Innsbruck	Austria	26
Néphrologie Dialyse St Guilhem	Sète	France	1